Dorsey Wright & Associates’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,933
Closed -$23.8K 307
2023
Q3
$23.8K Sell
1,933
-67
-3% -$826 0.01% 212
2023
Q2
$24.6K Buy
2,000
+201
+11% +$2.47K 0.01% 218
2023
Q1
$22.1K Buy
+1,799
New +$22.1K 0.01% 211